Fingerprint
Dive into the research topics of 'First Experience with 177Lu-PSMA-617 Therapy for Advanced Prostate Cancer in the Netherlands'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically
First Experience with 177Lu-PSMA-617 Therapy for Advanced Prostate Cancer in the Netherlands
Ludwike van Kalmthout, Arthur Braat, Marnix Lam, Rachel van Leeuwaarde, Gerard Krijger, Tessa Ververs, Niven Mehra, Adriaan Bins, Jarmo Hunting, Bart de Keizer
Research output: Contribution to journal › Article › Academic › peer-review